Company: IMXI
Filing Date: 2025-10-21
Form Type: PREM14A
Source: 0001140361-25-038818
Chunk: 99

Company: International Money Express, Inc.
Filing Date: 2025-10-21
Form: PREM14A
Chunk 99
---
 fair value of Intermex, and Lazard was not furnished with any such valuation or appraisal. Management of Intermex advised Lazard that the Moderate Case Management Forecasts utilized in Lazard’s analyses reflected their best currently available estimates and judgments as to the future financial performance of Intermex. Accordingly, the Strategic Alternatives Committee instructed Lazard to use only such forecasts for purposes of Lazard’s analyses in connection with its opinion. With respect to the financial forecasts utilized in Lazard’s analyses, Lazard assumed, with the consent of the Strategic

58

#### TABLE OF CONTENTS
Alternatives Committee, that they had been reasonably prepared on bases reflecting the best currently available estimates and judgments as to the future financial performance of Intermex. Lazard assumed no responsibility for and expressed no view as to any such forecasts or the assumptions on which they are based.

Further, Lazard’s opinion was necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to Lazard as of, the date of its opinion. Lazard further noted that volatility in the credit, commodities and financial markets may have an effect on Intermex or the Merger and Lazard did not express an opinion as to the effects of such volatility on Intermex or the Merger. Lazard assumed no responsibility for updating or revising its opinion based on circumstances or events occurring after the date thereof. Lazard did not express any opinion as to the price at which shares of our common stock may trade at any time subsequent to the announcement of the Merger. In connection with its engagement, Lazard was not authorized to, and did not, solicit indications of interest from third parties regarding a potential transaction with Intermex. In addition, Lazard’s opinion did not address the relative merits of the Merger as compared to any other transaction or business strategy in which Intermex might engage or the merits of the underlying decision by Intermex to engage in the Merger.

In rendering its opinion, Lazard assumed, with the consent of the Strategic Alternatives Committee, that the Merger would be consummated on the terms described in the Merger Agreement, without any waiver or modification of any material terms or conditions. Lazard also assumed, with the consent of the Strategic Alternatives Committee, that obtaining the necessary governmental, regulatory or third-party approvals and consents for the Merger would not have an adverse effect on Intermex or the Merger. Lazard did not express any opinion as to any